Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00036413
Status:
COMPLETED
Last Update Posted:
2011-11-24
First Post:
2002-05-09
Brief Title:
A 12-week Multicenter Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Amyotrophic Lateral Sclerosis |
Keywords:
| Name | View |
|---|---|
| ALS | View |